RAPT Therapeutics $75 million follow-on offering
Davis Polk advised the underwriters in connection with a $75 million public offering of common stock by RAPT Therapeutics, Inc. RAPT Therapeutics’ common stock is listed on the …
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Grocery Outlet Holding $528 million secondary offering
Davis Polk advised the underwriters in connection with the $528 million SEC-registered offering of 16,000,000 shares of common stock of Grocery Outlet Holding Corp. by certain existing…
Equinix acquisition of Packet Host
Davis Polk is advising Equinix, Inc. in connection with its acquisition of Packet Host Inc., the leading bare metal automation platform that provides innovative and developer-oriented bare…
Kodiak Sciences Inc. $317 Million Follow-On Offering
Davis Polk advised the joint bookrunning managers and representatives of the several underwriters in connection with a $317.4 million public offering of common stock by Kodiak Sciences Inc…
Revance Therapeutics, Inc. $110 Million Common Stock Offering
Davis Polk advised the joint lead book-running managers and representatives of the several underwriters in connection with a $110.5 million SEC-registered common stock offering by…
Davis Polk Advises Equinix, Inc. on Its $2.8 Billion Senior Notes Offering and Concurrent Tender Offer
Davis Polk advised Equinix, Inc. on an SEC-registered offering of $2.8 billion aggregate principal amount of senior notes. The offering consisted of $1 billion aggregate principal amount of…
Grocery Outlet Holding Corp. $439 Million Secondary Offering
Davis Polk advised the underwriters in connection with the $439 million SEC-registered offering of common stock of Grocery Outlet Holding Corp. by certain existing stockholders of Grocery…
Harmonic Inc. $115.5 Million Convertible Senior Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Harmonic Inc. of $115.5 million aggregate principal amount of its 2.00% convertible senior notes due…
Turning Point Therapeutics, Inc. $202.5 Million Follow-On Offering
Davis Polk advised the underwriters in connection with a $202.5 million public offering of common stock by Turning Point Therapeutics, Inc. Turning Point Therapeutics’ common stock is…
Davis Polk Advises Texas Instruments on Its $750 Million Notes Offering
Davis Polk advised Texas Instruments Incorporated on its SEC-registered debt offering of $750 million aggregate principal amount of 2.250% notes due 2029.
Texas Instruments is a global…